NCT00026819View on ClinicalTrials.gov

Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

November 30, 2003

Conditions
Pain
Interventions
DRUG

Rofecoxib

Trial Locations (1)

20892

National Institute of Dental And Craniofacial Research (NIDCR), Bethesda

All Listed Sponsors
lead

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

NCT00026819 - Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction | Biotech Hunter | Biotech Hunter